TGF-β has been demonstrated to instigate a shift in metabolic reprogramming from oxidative phosphorylation to glycolysis within glioblastoma, creating an immunosuppressive environment conducive to tumor growth [27]. This evidence concerns the gene TGFB1 and neoplasm.